Search Tag: idarucizumab

2025 27 May

What is the most effective way to control bleeding in patients taking direct oral anticoagulants (DOACs)? Are reversal agents warranted in every case? These are among the key questions addressed during a lightning talk at Euroanaesthesia 2025.    As the global use of DOACs continues to rise, the need for clinicians to confidently manage associated...Read more

2024 30 Jul

  Direct oral anticoagulants (DOACs) like apixaban, edoxaban, rivaroxaban (all FXa inhibitors), and dabigatran (a thrombin inhibitor) have been used for many years, with their generic versions becoming increasingly available. Though DOACs have a lower risk of serious bleeding, such as intracranial haemorrhage, compared to vitamin K antagonists, bleeding...Read more